Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Sep 7;6:32541. doi: 10.1038/srep32541

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2016, The Author(s)

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

PMC Copyright notice

(A) miR-564 expression analysis in GSE40525 dataset containing 56 matched breast cancer patient samples. (B) miR-564 expression in breast cancer patients with low proliferative (LP) and high proliferative (HP) tumors in GSE19536 dataset. (C,D) miR-564 expression in breast cancer patients from GSE22220 and GSE40267 datasets grouped according to tumor grades. Data were used as it is provided. For GSE22220 dataset low and high grades were defined as grade 1 and 3, respectively. (E) Patient miR-564 levels in 14 primary and 27 metastatic tumors from GSE37407 dataset. (F) miR-564 expression levels in patients showing different stages in breast cancer tumor progression (GSE38867). (G) Distant Relapse Free Survival (DRFS) of breast cancer patients from GSE22220 dataset in correlation to miR-564 expression levels. Patients were separated from median miR-564 expression value and survival graph had a follow-up for 5 years.